Literature DB >> 26105538

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence.

Holly E Barker1, James T E Paget1, Aadil A Khan1, Kevin J Harrington1.   

Abstract

Radiotherapy plays a central part in curing cancer. For decades, most research on improving treatment outcomes has focused on modulating radiation-induced biological effects on cancer cells. Recently, we have better understood that components within the tumour microenvironment have pivotal roles in determining treatment outcomes. In this Review, we describe vascular, stromal and immunological changes that are induced in the tumour microenvironment by irradiation and discuss how these changes may promote radioresistance and tumour recurrence. We also highlight how this knowledge is guiding the development of new treatment paradigms in which biologically targeted agents will be combined with radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26105538      PMCID: PMC4896389          DOI: 10.1038/nrc3958

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  193 in total

1.  The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.

Authors:  Sergio Carracedo; Ning Lu; Svetlana N Popova; Roland Jonsson; Beate Eckes; Donald Gullberg
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

2.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

Review 3.  Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).

Authors:  Heon Joo Park; Robert J Griffin; Susanta Hui; Seymour H Levitt; Chang W Song
Journal:  Radiat Res       Date:  2012-01-09       Impact factor: 2.841

4.  Intratumoral hypoxia, radiation resistance, and HIF-1.

Authors:  Gregg L Semenza
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

Review 5.  Tumour immunity: effector response to tumour and role of the microenvironment.

Authors:  Alberto Mantovani; Pedro Romero; A Karolina Palucka; Francesco M Marincola
Journal:  Lancet       Date:  2008-02-13       Impact factor: 79.321

6.  Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.

Authors:  Peter Hoskin; Ana Rojas; Michele Saunders
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-25       Impact factor: 7.038

7.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies.

Authors:  Inge Verbrugge; Jim Hagekyriakou; Leslie L Sharp; Mara Galli; Alison West; Nicole M McLaughlin; Hélène Duret; Hideo Yagita; Ricky W Johnstone; Mark J Smyth; Nicole M Haynes
Journal:  Cancer Res       Date:  2012-05-08       Impact factor: 12.701

9.  MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.

Authors:  Aruna Venkata Badiga; Chandramu Chetty; Divya Kesanakurti; Deepthi Are; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced.

Authors:  Turid Hellevik; Ingvild Pettersen; Vivian Berg; Jan Olof Winberg; Bjørn T Moe; Kristian Bartnes; Ruth H Paulssen; Lill-Tove Busund; Roy Bremnes; Anthony Chalmers; Iñigo Martinez-Zubiaurre
Journal:  Radiat Oncol       Date:  2012-04-13       Impact factor: 3.481

View more
  488 in total

Review 1.  Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.

Authors:  Shankar Siva; Gargi Kothari; Alexander Muacevic; Alexander V Louie; Ben J Slotman; Bin S Teh; Simon S Lo
Journal:  Nat Rev Urol       Date:  2017-06-20       Impact factor: 14.432

2.  Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.

Authors:  Xiaowei Chen; Yoshihiro Takemoto; Huan Deng; Moritz Middelhoff; Richard A Friedman; Timothy H Chu; Michael J Churchill; Yan Ma; Karan K Nagar; Yagnesh H Tailor; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

3.  Abscopal effect of metastatic pancreatic cancer after local radiotherapy and granulocyte-macrophage colony-stimulating factor therapy.

Authors:  Fang Shi; Xin Wang; Feifei Teng; Li Kong; Jinming Yu
Journal:  Cancer Biol Ther       Date:  2017-03-04       Impact factor: 4.742

4.  Cancer recurrence monitoring using hyperpolarized [1-13C]pyruvate metabolic imaging in murine breast cancer model.

Authors:  Peter J Shin; Zihan Zhu; Roman Camarda; Robert A Bok; Alicia Y Zhou; John Kurhanewicz; Andrei Goga; Daniel B Vigneron
Journal:  Magn Reson Imaging       Date:  2017-07-15       Impact factor: 2.546

5.  Role of Angiogenesis in Chronic Radiation Proctitis: New Evidence Favoring Inhibition of Angiogenesis Ex Vivo.

Authors:  Peihuang Wu; Li Li; Huaiming Wang; Tenghui Ma; Haiyong Wu; Xinjuan Fan; Zihuan Yang; Daici Chen; Lei Wang
Journal:  Dig Dis Sci       Date:  2017-10-27       Impact factor: 3.199

6.  Biodosimetric transcriptional and proteomic changes are conserved in irradiated human tissue.

Authors:  Simon P Keam; Twishi Gulati; Cristina Gamell; Franco Caramia; Gisela Mir Arnau; Cheng Huang; Ralf B Schittenhelm; Oded Kleifeld; Paul J Neeson; Scott G Williams; Ygal Haupt
Journal:  Radiat Environ Biophys       Date:  2018-05-30       Impact factor: 1.925

7.  Tumour radiosensitivity is associated with immune activation in solid tumours.

Authors:  Tobin Strom; Louis B Harrison; Anna R Giuliano; Michael J Schell; Steven A Eschrich; Anders Berglund; William Fulp; Ram Thapa; Domenico Coppola; Sungjune Kim; Jessica Frakes; John Foekens; James J Mulé; Javier F Torres-Roca
Journal:  Eur J Cancer       Date:  2017-08-29       Impact factor: 9.162

Review 8.  Making Checkpoint Inhibitors Part of Treatment of Patients With Locally Advanced Lung Cancers: The Time Is Now.

Authors:  Mark G Kris; Corinne Faivre-Finn; Tiana Kordbacheh; Jamie Chaft; Jia Luo; Anne Tsao; Stephen Swisher
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

9.  β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer.

Authors:  Jia Ma; Yanwei Lu; Sheng Zhang; Yan Li; Jing Huang; Zhongyuan Yin; Jinghua Ren; Kai Huang; Li Liu; Kunyu Yang; Gang Wu; Shuangbing Xu
Journal:  Cell Death Differ       Date:  2018-02-02       Impact factor: 15.828

10.  Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Authors:  Eleni M Rettig; Carole Fakhry; Russell K Hales; Flora Kisuule; Harry Quon; Ana P Kiess; Linda X Yin; Yuehan Zhang; Amanda L Blackford; M Bradley Drummond; Christine G Gourin; Wayne M Koch; David W Eisele; Gypsyamber D'Souza
Journal:  Head Neck       Date:  2018-03-15       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.